ADMA Competitors & Alternatives
Compare ADMA Biologics Inc with similar stocks in the same industry
Biotechnology
ADMA
Main Stock$8.59
Tradestie Score
47
Market Cap
$3.59B
P/E Ratio
12.9
Revenue Growth
0.2%
Analyst Upside
+97.9%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$22.58
|
$2.22B | - | 56 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.58
|
$2.21B | - | 55 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$23.83
|
$2.18B | - | 51 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$16.42
|
$2.08B | - | 56 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$16.21
|
$2.02B | 49.2 | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.47
|
$2.01B | - | 51 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$39.64
|
$1.97B | - | 55 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$8.93
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$91.69
|
$1.92B | - | 46 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$80.89
|
$1.90B | 481.8 | 52 | Compare |
More ADMA Analysis
Data updated: Jul 21, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry